Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Master, V; Roberts, GW; Coulthard, KP; Baghurst, PA; Martin, A; Roberts, ME; Onishko, CR; Martin, AJ; Linke, RJ; Holmes, M; Jarvinen, A; Kennedy, D; Colebatch, KA; Hansman, D; Parsons, DW
   Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: A preliminary study
   PEDIATRIC PULMONOLOGY
   
   V. Master et al., "Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: A preliminary study", PEDIAT PULM, 31(5), 2001, pp. 367-376
2. Rousseau, MN; Vergne, L; Montes, B; Peeters, M; Reynes, J; Delaporte, E; Segondy, M
   Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-Infected patients with failure of highly active antiretroviral therapy
   JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
   
   M.N. Rousseau et al., "Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-Infected patients with failure of highly active antiretroviral therapy", J ACQ IMM D, 26(1), 2001, pp. 36-43
3. Becker, SL; Raffanti, SR; Hansen, NI; Fusco, JS; Fusco, GP; Slatko, GH; Igboko, EF; Graham, NMH
   Zidovudine and stavudine sequencing in HIV treatment planning: Findings from the CHORUS HIV cohort
   JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
   
   S.L. Becker et al., "Zidovudine and stavudine sequencing in HIV treatment planning: Findings from the CHORUS HIV cohort", J ACQ IMM D, 26(1), 2001, pp. 72-81
4. Iversen, P; Melezinek, I; Schmidt, A
   Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function
   BJU INTERNATIONAL
   
   P. Iversen et al., "Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function", BJU INT, 87(1), 2001, pp. 47-56
5. Carrascosa, JM; Molero, JC; Fermin, Y; Martinez, C; Andres, A; Satrustegui, J
   Effects of chronic treatment with acarbose on glucose and lipid metabolismin obese diabetic Wistar rats
   DIABETES OBESITY & METABOLISM
   
   J.M. Carrascosa et al., "Effects of chronic treatment with acarbose on glucose and lipid metabolismin obese diabetic Wistar rats", DIABET OB M, 3(4), 2001, pp. 240-248
6. Eri, LM; Tveter, KJ
   Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA),acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH)
   PROSTATE CANCER AND PROSTATIC DISEASES
   
   L.M. Eri e K.J. Tveter, "Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA),acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH)", PROSTATE C, 4(3), 2001, pp. 173-177
7. Schasfoort, EMC; van de Beek, C; Newling, DWW
   Safety and efficacy of a nonsteroidal anti-androgen, based on results of apost marketing surveillance of nilutamide
   PROSTATE CANCER AND PROSTATIC DISEASES
   
   E.M.C. Schasfoort et al., "Safety and efficacy of a nonsteroidal anti-androgen, based on results of apost marketing surveillance of nilutamide", PROSTATE C, 4(2), 2001, pp. 112-117
8. McMahon, D; Lederman, M; Haas, DW; Haubrich, R; Stanford, J; Cooney, E; Horton, J; Kelleher, D; Ross, L; Cutrell, A; Lee, D; Spreen, W; Mellors, JW
   Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults
   ANTIVIRAL THERAPY
   
   D. McMahon et al., "Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults", ANTIVIR TH, 6(2), 2001, pp. 105-114
9. McGill, JB
   Angiotensin II receptor antagonist plus a thiazide diuretic is more efficacious for treating hypertension than either drug alone
   BLOOD PRESSURE MONITORING
   
   J.B. McGill, "Angiotensin II receptor antagonist plus a thiazide diuretic is more efficacious for treating hypertension than either drug alone", BL PRESS M, 6, 2001, pp. S3-S13
10. Hilleman, DE
    Pharmacoeconomics of combination antihypertensive therapy
    BLOOD PRESSURE MONITORING
    
    D.E. Hilleman, "Pharmacoeconomics of combination antihypertensive therapy", BL PRESS M, 6, 2001, pp. S31-S36
11. Macritchie, KAN; Ferrier, IN
    Bipolar affective disorder and anticonvulsant mood stabilizers
    PRIMARY CARE PSYCHIATRY
    
    K.A.N. Macritchie e I.N. Ferrier, "Bipolar affective disorder and anticonvulsant mood stabilizers", PRIM CARE P, 7(2), 2001, pp. 49-53
12. Reaven, GM
    Insulin resistance: why is it important to treat?
    DIABETES & METABOLISM
    
    G.M. Reaven, "Insulin resistance: why is it important to treat?", DIABETE MET, 27(2), 2001, pp. 247-253
13. Kalviainen, R; Nousiainen, I
    Visual field defects with vigabatrin - Epidemiology and therapeutic implications
    CNS DRUGS
    
    R. Kalviainen e I. Nousiainen, "Visual field defects with vigabatrin - Epidemiology and therapeutic implications", CNS DRUGS, 15(3), 2001, pp. 217-230
14. Brodie, MJ; Kwan, P
    The Star Systems - Overview and use in determining antiepileptic drug choice
    CNS DRUGS
    
    M.J. Brodie e P. Kwan, "The Star Systems - Overview and use in determining antiepileptic drug choice", CNS DRUGS, 15(1), 2001, pp. 1-12
15. Castagnola, E; Da Ros, L
    Temporary interruption of ceftazidime continuous infusion without reduction of activity: A computer-assisted simulation
    JOURNAL OF CHEMOTHERAPY
    
    E. Castagnola e L. Da Ros, "Temporary interruption of ceftazidime continuous infusion without reduction of activity: A computer-assisted simulation", J CHEMOTHER, 13(4), 2001, pp. 395-401
16. Agaoglu, L; Devecioglu, O; Anak, S; Karakas, Z; Yalman, N; Biner, B; Eryilmaz, E; Goksan, B; Unuvar, A; Agirbasli, H; Can, M; Bilgen, H; Gedikoglu, G
    Cost-effectiveness of cefepime plus netilmicin or ceftazidime plus amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey
    JOURNAL OF CHEMOTHERAPY
    
    L. Agaoglu et al., "Cost-effectiveness of cefepime plus netilmicin or ceftazidime plus amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey", J CHEMOTHER, 13(3), 2001, pp. 281-287
17. Bonanno, DG; Davydov, L; Botts, SR
    Olanzapine-induced diabetes mellitus
    ANNALS OF PHARMACOTHERAPY
    
    D.G. Bonanno et al., "Olanzapine-induced diabetes mellitus", ANN PHARMAC, 35(5), 2001, pp. 563-565
18. Lam, J; Rozsavolgyi, M; Soos, G; Vincze, Z; Rajna, P
    Quality of life of patients with epilepsy (Hungarian survey)
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
    
    J. Lam et al., "Quality of life of patients with epilepsy (Hungarian survey)", SEIZURE-E J, 10(2), 2001, pp. 100-106
19. Montagnino, G; Tarantino, A; Segoloni, GP; Cambi, V; Rizzo, G; Altieri, P; Castagneto, M; Salvadori, M; Cossu, M; Pisani, F; Carmellini, M; Mastrangelo, F; Ferrara, R; Ponticelli, C
    Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    G. Montagnino et al., "Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation", J AM S NEPH, 12(10), 2001, pp. 2163-2169
20. Bauduer, F; Cousin, T; Boulat, O; Rigal-Huguet, F; Molina, L; Fegueux, N; Jourdan, E; Boiron, JM; Reiffers, J
    A randomized prospective multicentre trial of cefpirome versus piperacillin-tazobactam in febrile neutropenia
    LEUKEMIA & LYMPHOMA
    
    F. Bauduer et al., "A randomized prospective multicentre trial of cefpirome versus piperacillin-tazobactam in febrile neutropenia", LEUK LYMPH, 42(3), 2001, pp. 379-386
21. Rini, BI; Small, EJ
    An update on prostate cancer
    CURRENT OPINION IN ONCOLOGY
    
    B.I. Rini e E.J. Small, "An update on prostate cancer", CURR OPIN O, 13(3), 2001, pp. 204-211
22. Waldmann, H; Cobbold, S
    Approaching tolerance in transplantation
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
    
    H. Waldmann e S. Cobbold, "Approaching tolerance in transplantation", INT A AL IM, 126(1), 2001, pp. 11-22
23. Calne, RY
    The future of organ transplantation: from the laboratory to the clinic
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    
    R.Y. Calne, "The future of organ transplantation: from the laboratory to the clinic", PHI T ROY B, 356(1409), 2001, pp. 767-771
24. Piot, O; Gallois, H; Baguet, JP; Mallion, JM
    First-line treatment of hypertension: from monotherapy to fixed low-dose combination therapy
    JOURNAL OF HUMAN HYPERTENSION
    
    O. Piot et al., "First-line treatment of hypertension: from monotherapy to fixed low-dose combination therapy", J HUM HYPER, 15(7), 2001, pp. 443-446
25. Fleischhack, G; Schmidt-Niemann, M; Wulff, B; Havers, W; Marklein, G; Hasan, C; Bode, U
    Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients
    SUPPORTIVE CARE IN CANCER
    
    G. Fleischhack et al., "Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients", SUPP CARE C, 9(5), 2001, pp. 372-379
26. Mulazimoglu, L
    Treatment of community-acquired pneumonia in hospitalised patients
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    L. Mulazimoglu, "Treatment of community-acquired pneumonia in hospitalised patients", INT J ANT A, 18, 2001, pp. S63-S70
27. Nieto-Barrera, M; Brozmanova, M; Capovilla, G; Christe, W; Pedersen, B; Kane, K; O'Neill, F
    A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy
    EPILEPSY RESEARCH
    
    M. Nieto-Barrera et al., "A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy", EPILEPSY R, 46(2), 2001, pp. 145-155
28. Brodie, MJ
    Monotherapy trials: prerequisite data
    EPILEPSY RESEARCH
    
    M.J. Brodie, "Monotherapy trials: prerequisite data", EPILEPSY R, 45(1-3), 2001, pp. 61-64
29. Pledger, G
    Monotherapy trials: presurgical studies
    EPILEPSY RESEARCH
    
    G. Pledger, "Monotherapy trials: presurgical studies", EPILEPSY R, 45(1-3), 2001, pp. 67-71
30. Kalviainen, R
    Monotherapy trial design: conversion versus de novo
    EPILEPSY RESEARCH
    
    R. Kalviainen, "Monotherapy trial design: conversion versus de novo", EPILEPSY R, 45(1-3), 2001, pp. 75-78
31. Schwabe, S
    Monotherapy comparative trials: placebos and suboptimal comparators
    EPILEPSY RESEARCH
    
    S. Schwabe, "Monotherapy comparative trials: placebos and suboptimal comparators", EPILEPSY R, 45(1-3), 2001, pp. 93-96
32. Chadwick, D
    Monotherapy comparative trials: equivalence and differences in clinical trials
    EPILEPSY RESEARCH
    
    D. Chadwick, "Monotherapy comparative trials: equivalence and differences in clinical trials", EPILEPSY R, 45(1-3), 2001, pp. 101-103
33. Mattson, RH
    Monotherapy trials: endpoints
    EPILEPSY RESEARCH
    
    R.H. Mattson, "Monotherapy trials: endpoints", EPILEPSY R, 45(1-3), 2001, pp. 109-117
34. Perucca, E
    Trial duration and follow-up
    EPILEPSY RESEARCH
    
    E. Perucca, "Trial duration and follow-up", EPILEPSY R, 45(1-3), 2001, pp. 123-127
35. Bien, CG; Elger, CE
    Monotherapy trials in antiepileptic drugs: are modified "presurgical studies" a way out of the dilemma?
    EPILEPSY RESEARCH
    
    C.G. Bien e C.E. Elger, "Monotherapy trials in antiepileptic drugs: are modified "presurgical studies" a way out of the dilemma?", EPILEPSY R, 44(1), 2001, pp. 1-5
36. Chen, YJ; Chow, JC; Lee, IC
    Comparison the cognitive effect of anti-epileptic drugs in seizure-free children with epilepsy before and after drug withdrawal
    EPILEPSY RESEARCH
    
    Y.J. Chen et al., "Comparison the cognitive effect of anti-epileptic drugs in seizure-free children with epilepsy before and after drug withdrawal", EPILEPSY R, 44(1), 2001, pp. 65-70
37. Brooks, J; Baker, GA; Aldenkamp, AP
    The A-B Neuropsychological Assessment Schedule (ABNAS): the further refinement of a patient-based scale of patient-perceived cognitive functioning
    EPILEPSY RESEARCH
    
    J. Brooks et al., "The A-B Neuropsychological Assessment Schedule (ABNAS): the further refinement of a patient-based scale of patient-perceived cognitive functioning", EPILEPSY R, 43(3), 2001, pp. 227-237
38. Coppola, G; Caliendo, G; Terracciano, MM; Buono, S; Pellegrino, L; Pascotto, A
    Topiramate in refractory partial-onset seizures in children, adolescents and young adults: a multicentric open trial
    EPILEPSY RESEARCH
    
    G. Coppola et al., "Topiramate in refractory partial-onset seizures in children, adolescents and young adults: a multicentric open trial", EPILEPSY R, 43(3), 2001, pp. 255-260
39. Bialer, M; Johannessen, SI; Kupferberg, HJ; Levy, RH; Loiseau, P; Perucca, E
    Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
    EPILEPSY RESEARCH
    
    M. Bialer et al., "Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)", EPILEPSY R, 43(1), 2001, pp. 11-58
40. Kitamura, T
    Necessity of re-evaluation of estramustine phosphate sodium (EMP) as a treatment option for first-line monotherapy in advanced prostate cancer
    INTERNATIONAL JOURNAL OF UROLOGY
    
    T. Kitamura, "Necessity of re-evaluation of estramustine phosphate sodium (EMP) as a treatment option for first-line monotherapy in advanced prostate cancer", INT J UROL, 8(2), 2001, pp. 33-36
41. Nelson, M; Reid, C; Krum, H; McNeil, J
    A systematic review of predictors of maintenance of normotension after withdrawal of antihypertensive drugs
    AMERICAN JOURNAL OF HYPERTENSION
    
    M. Nelson et al., "A systematic review of predictors of maintenance of normotension after withdrawal of antihypertensive drugs", AM J HYPERT, 14(2), 2001, pp. 98-105
42. Dretler, SP; Spencer, BA
    CT and stone fragility
    JOURNAL OF ENDOUROLOGY
    
    S.P. Dretler e B.A. Spencer, "CT and stone fragility", J ENDOUROL, 15(1), 2001, pp. 31-36
43. Saez-Llorens, X; O'Ryan, M
    Cefepime in the empiric treatment of meningitis in children
    PEDIATRIC INFECTIOUS DISEASE JOURNAL
    
    X. Saez-Llorens e M. O'Ryan, "Cefepime in the empiric treatment of meningitis in children", PEDIAT INF, 20(3), 2001, pp. 356-361
44. Mustafa, MM; Carlson, L; Tkaczewski, I; McCracken, GH; Buchanan, GR
    Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia
    PEDIATRIC INFECTIOUS DISEASE JOURNAL
    
    M.M. Mustafa et al., "Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia", PEDIAT INF, 20(3), 2001, pp. 362-369
45. Katzenstein, DA; Hughes, MD; Albrecht, M; Liou, SH; Murphy, R; Balfour, H; Para, M; Hammer, S
    Virologic and CD4 cell response to zidovudine or zidovudine and lamivudinefollowing didanosine treatment of human immunodeficiency virus infection
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    D.A. Katzenstein et al., "Virologic and CD4 cell response to zidovudine or zidovudine and lamivudinefollowing didanosine treatment of human immunodeficiency virus infection", AIDS RES H, 17(3), 2001, pp. 203-210
46. Ross, L; Scarsella, A; Raffanti, S; Henry, K; Becker, S; Fisher, R; Liao, QM; Hirani, A; Graham, N; St Clair, M; Hernandez, J
    Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolatedfrom zidovudine-naive patients experiencing viremia on stavudine-containing regimens
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    L. Ross et al., "Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolatedfrom zidovudine-naive patients experiencing viremia on stavudine-containing regimens", AIDS RES H, 17(12), 2001, pp. 1107-1115
47. Verrotti, A; Basciani, F; Morresi, S; Morgese, G; Chiarelli, F
    Thyroid hormones in epileptic children receiving carbamazepine and valproic acid
    PEDIATRIC NEUROLOGY
    
    A. Verrotti et al., "Thyroid hormones in epileptic children receiving carbamazepine and valproic acid", PED NEUROL, 25(1), 2001, pp. 43-46
48. Westheim, A; Klemetsrud, T; Tretli, S; Stokke, HP; Olsen, H
    Blood pressure levels in treated hypertensive patients in general practicein Norway
    BLOOD PRESSURE
    
    A. Westheim et al., "Blood pressure levels in treated hypertensive patients in general practicein Norway", BLOOD PRESS, 10(1), 2001, pp. 37-42
49. Razis, E; Dimopoulus, AM; Bafaloukos, D; Papadimitriou, C; Kalogera-Fountzila, A; Kalofonos, H; Briassoulis, E; Samantas, E; Keramopoulos, A; Pavlidis, N; Kosmidis, P; Fountzilas, G
    Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer
    CANCER INVESTIGATION
    
    E. Razis et al., "Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer", CANCER INV, 19(2), 2001, pp. 137-144
50. Zerjav-Lacombe, S; Tabarsi, E
    Lamotrigine: A review of clinical studies in bipolar disorders
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    
    S. Zerjav-Lacombe e E. Tabarsi, "Lamotrigine: A review of clinical studies in bipolar disorders", CAN J PSY, 46(4), 2001, pp. 328-333
51. Alvarez-Lerma, F; Insausti-Ordenana, J; Jorda-Marcos, R; Maravi-Poma, E; Torres-Marti, A; Nava, J; Martinez-Pellus, A; Palomar, M; Barcenilla, F
    Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime inassociation with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial
    INTENSIVE CARE MEDICINE
    
    F. Alvarez-Lerma et al., "Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime inassociation with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial", INTEN CAR M, 27(3), 2001, pp. 493-502
52. Iversen, P; Abrahamsson, PA; Mulders, PFA
    Advanced prostate cancer
    EUROPEAN UROLOGY
    
    P. Iversen et al., "Advanced prostate cancer", EUR UROL, 39(6), 2001, pp. A1-A10
53. Abrahamsson, PA
    Treatment of locally advanced prostate cancer - A new role for antiandrogen monotherapy?
    EUROPEAN UROLOGY
    
    P.A. Abrahamsson, "Treatment of locally advanced prostate cancer - A new role for antiandrogen monotherapy?", EUR UROL, 39, 2001, pp. 22-28
54. Matsumoto, H; Nakao, T; Okada, T; Nagaoka, Y; Shino, T; Yoshino, M; Hidaka, H
    Initial remission-inducing effect of very low-dose cyclosporin monotherapyfor minimal-change nephrotic syndrome in Japanese adults
    CLINICAL NEPHROLOGY
    
    H. Matsumoto et al., "Initial remission-inducing effect of very low-dose cyclosporin monotherapyfor minimal-change nephrotic syndrome in Japanese adults", CLIN NEPHR, 55(2), 2001, pp. 143-148
55. Mungersdorf, M; Sommer, U; Sommer, M; Reichmann, H
    High-dose therapy with ropinirole in patients with Parkinson's disease
    JOURNAL OF NEURAL TRANSMISSION
    
    M. Mungersdorf et al., "High-dose therapy with ropinirole in patients with Parkinson's disease", J NEURAL TR, 108(11), 2001, pp. 1309-1317
56. Salman, S; Salman, F; Satman, I; Yilmaz, Y; Ozer, E; Sengul, A; Demirel, HO; Karsidag, K; Dinccag, N; Yilmaz, MT
    Comparison of acarbose and gliclazide as first-line agents in patients with type 2 diabetes
    CURRENT MEDICAL RESEARCH AND OPINION
    
    S. Salman et al., "Comparison of acarbose and gliclazide as first-line agents in patients with type 2 diabetes", CURR MED R, 16(4), 2001, pp. 296-306
57. Banks, MK; Besheer, J; Szypczak, J; Goodpaster, LL; Phipps, EJ; Garraghty, PE
    The effects of carbamazepine on an appetitive-to-aversive transfer task: Comparison to untreated and phenytoin
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    
    M.K. Banks et al., "The effects of carbamazepine on an appetitive-to-aversive transfer task: Comparison to untreated and phenytoin", PROG NEUR-P, 25(3), 2001, pp. 551-572
58. Cheng, SJ; Bonis, PAL; Lau, J; Pham, NQ; Wong, JB
    Interferon and ribavirin for patients with chronic hepatitis C who did notrespond to previous interferon therapy: A meta-analysis of controlled and uncontrolled trials
    HEPATOLOGY
    
    S.J. Cheng et al., "Interferon and ribavirin for patients with chronic hepatitis C who did notrespond to previous interferon therapy: A meta-analysis of controlled and uncontrolled trials", HEPATOLOGY, 33(1), 2001, pp. 231-240
59. Kaul, A; Kalla, NR; Goyle, S
    I. The modulatory effect in genotoxic responses due to age and duration ofPHT-therapy in epileptic patients
    TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS
    
    A. Kaul et al., "I. The modulatory effect in genotoxic responses due to age and duration ofPHT-therapy in epileptic patients", TER CAR MUT, 21(2), 2001, pp. 135-149
60. Kodama, H; Kodama, Y; Itokazu, N; Shinozawa, S; Kanemaru, R; Sugimoto, T
    Effect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    
    H. Kodama et al., "Effect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy", J CLIN PH T, 26(3), 2001, pp. 175-179
61. Waeber, B; Aschwanden, R; Sadecky, L; Ferber, P
    Combination of hydrochlorothiazide or benazepril with valsartan in hypertensive patients unresponsive to valsartan alone
    JOURNAL OF HYPERTENSION
    
    B. Waeber et al., "Combination of hydrochlorothiazide or benazepril with valsartan in hypertensive patients unresponsive to valsartan alone", J HYPERTENS, 19(11), 2001, pp. 2097-2104
62. Ridwelski, K; Meyer, F
    Current options for palliative treatment in patients with pancreatic cancer
    DIGESTIVE DISEASES
    
    K. Ridwelski e F. Meyer, "Current options for palliative treatment in patients with pancreatic cancer", DIGEST DIS, 19(1), 2001, pp. 63-75
63. Calabrese, JR; Shelton, MD; Bowden, CL; Rapport, DJ; Suppes, T; Shirley, ER; Kimmel, SE; Caban, SJ
    Bipolar rapid cycling: Focus on depression as its hallmark
    JOURNAL OF CLINICAL PSYCHIATRY
    
    J.R. Calabrese et al., "Bipolar rapid cycling: Focus on depression as its hallmark", J CLIN PSY, 62, 2001, pp. 34-41
64. Laffitte, E; Borradori, L
    Management of bullous pemphigoid
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
    
    E. Laffitte e L. Borradori, "Management of bullous pemphigoid", ANN DER VEN, 128(5), 2001, pp. 677-680
65. Miyazaki, Y; Mahankali, A; Matsuda, M; Glass, L; Mahankali, S; Ferrannini, E; Cusi, K; Mandarino, LJ; DeFronzo, RA
    Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone
    DIABETES CARE
    
    Y. Miyazaki et al., "Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone", DIABET CARE, 24(4), 2001, pp. 710-719
66. Kalis, MM; Huff, NA
    Oxcarbazepine, an antiepileptic agent
    CLINICAL THERAPEUTICS
    
    M.M. Kalis e N.A. Huff, "Oxcarbazepine, an antiepileptic agent", CLIN THER, 23(5), 2001, pp. 680-700
67. Simmons, ST
    Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension
    CLINICAL THERAPEUTICS
    
    S.T. Simmons, "Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension", CLIN THER, 23(4), 2001, pp. 604-619
68. Gale, EAM
    Lessons from the glitazones: a story of drug development
    LANCET
    
    E.A.M. Gale, "Lessons from the glitazones: a story of drug development", LANCET, 357(9271), 2001, pp. 1870-1875
69. Mani, KS; Rangan, G; Srinivas, HV; Srindharan, VS; Subbakrishna, DK
    Epilepsy control with phenobarbital or phenytoin in rural south India: theYelandur study
    LANCET
    
    K.S. Mani et al., "Epilepsy control with phenobarbital or phenytoin in rural south India: theYelandur study", LANCET, 357(9265), 2001, pp. 1316-1320
70. Kwan, P; Brodie, MJ
    Neuropsychological effects of epilepsy and antiepileptic drugs
    LANCET
    
    P. Kwan e M.J. Brodie, "Neuropsychological effects of epilepsy and antiepileptic drugs", LANCET, 357(9251), 2001, pp. 216-222
71. Spence, SJ; Sankar, R
    Visual field defects and other ophthalmological disturbances associated with vigabatrin
    DRUG SAFETY
    
    S.J. Spence e R. Sankar, "Visual field defects and other ophthalmological disturbances associated with vigabatrin", DRUG SAFETY, 24(5), 2001, pp. 385-404
72. Jallon, P; Picard, F
    Bodyweight gain and anticonvulsants - A comparative review
    DRUG SAFETY
    
    P. Jallon e F. Picard, "Bodyweight gain and anticonvulsants - A comparative review", DRUG SAFETY, 24(13), 2001, pp. 969-978
73. Etminan, M; Samii, A; Takkouche, B; Rochon, PA
    Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease - A meta-analysis of randomised controlled trials
    DRUG SAFETY
    
    M. Etminan et al., "Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease - A meta-analysis of randomised controlled trials", DRUG SAFETY, 24(11), 2001, pp. 863-868
74. Kolvenbag, GJCM; Iversen, P; Newling, DWW
    Antiandrogen monotherapy: A new form of treatment for patients with prostate cancer
    UROLOGY
    
    G.J.C.M. Kolvenbag et al., "Antiandrogen monotherapy: A new form of treatment for patients with prostate cancer", UROLOGY, 58(2A), 2001, pp. 16-22
75. Grossfeld, GD; Small, EJ; Lubeck, DP; Latini, D; Broering, JM; Carroll, PR
    Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy
    UROLOGY
    
    G.D. Grossfeld et al., "Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy", UROLOGY, 58(2A), 2001, pp. 56-64
76. Trump, DL; Waldstreicher, JA; Kolvenbag, G; Wissel, PS; Neubauer, BL
    Androgen antagonists: Potential role in prostate cancer prevention
    UROLOGY
    
    D.L. Trump et al., "Androgen antagonists: Potential role in prostate cancer prevention", UROLOGY, 57(4A), 2001, pp. 64-67
77. Lebovitz, HE; Banerji, MA
    Insulin resistance and its treatment by thiazolidinediones
    RECENT PROGRESS IN HORMONE RESEARCH, VOL 56
    
    H.E. Lebovitz e M.A. Banerji, "Insulin resistance and its treatment by thiazolidinediones", REC PROG H, 56, 2001, pp. 265-294
78. Berg, T; Naumann, U; Wiedenmann, B; Hopf, U
    Pilot study of interferon-alpha high-dose induction therapy in combinationwith ribavirin plus amantadine for nonresponder patients with chronic hepatitis C
    ZEITSCHRIFT FUR GASTROENTEROLOGIE
    
    T. Berg et al., "Pilot study of interferon-alpha high-dose induction therapy in combinationwith ribavirin plus amantadine for nonresponder patients with chronic hepatitis C", Z GASTROENT, 39(2), 2001, pp. 145
79. Dykes, C; Fox, K; Lloyd, A; Chiulli, M; Morse, E; Demeter, LM
    Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants
    VIROLOGY
    
    C. Dykes et al., "Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants", VIROLOGY, 285(2), 2001, pp. 193-203
80. Grinyo, JM
    Overcoming toxicities: New regimens
    TRANSPLANTATION PROCEEDINGS
    
    J.M. Grinyo, "Overcoming toxicities: New regimens", TRANSPLAN P, 33(3A), 2001, pp. 4S-6S
81. Washburn, K; Speeg, KV; Esterl, R; Cigarroa, F; Pollack, M; Tourtellot, C; Maxwell, P; Halff, G
    Steroid elimination 24 hours after liver transplantation using daclizumab,tacrolimus, and mycophenolate mofetil
    TRANSPLANTATION
    
    K. Washburn et al., "Steroid elimination 24 hours after liver transplantation using daclizumab,tacrolimus, and mycophenolate mofetil", TRANSPLANT, 72(10), 2001, pp. 1675-1679
82. Ko, S; Jager, MD; Tsui, TY; Deiwick, A; Dinkel, A; Rohde, F; Dahlke, MH; Lauth, O; Wonigeit, K; Schlitt, HJ
    Long-term allograft acceptance induced by single dose anti-leukocyte common antigen (RT7) antibody in the rat
    TRANSPLANTATION
    
    S. Ko et al., "Long-term allograft acceptance induced by single dose anti-leukocyte common antigen (RT7) antibody in the rat", TRANSPLANT, 71(8), 2001, pp. 1124-1131
83. Erman, M; Akova, M; Akan, H; Korten, V; Ferhanoglu, B; Koksal, I; Cetinkaya, Y; Uzun, O; Unal, S
    Comparison of cefepime and ceftazidime in combination with amikacin in theempirical treatment of high-risk patients with febrile neutropenia: A prospective, randomized, multicenter study
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    
    M. Erman et al., "Comparison of cefepime and ceftazidime in combination with amikacin in theempirical treatment of high-risk patients with febrile neutropenia: A prospective, randomized, multicenter study", SC J IN DIS, 33(11), 2001, pp. 827-831
84. Vogel, CL; Cobleigh, MA; Tripathy, D; Gutheil, JC; Harris, LN; Fehrenbacher, L; Slamon, DJ; Murphy, M; Novotny, WF; Burchmore, M; Shak, S; Stewart, SJ
    First-line Herceptin (R) monotherapy in metastatic breast cancer
    ONCOLOGY
    
    C.L. Vogel et al., "First-line Herceptin (R) monotherapy in metastatic breast cancer", ONCOL-BASEL, 61, 2001, pp. 37-42
85. Sachdeo, R; Beydoun, A; Schachter, S; Vazquez, B; Schaul, N; Mesenbrink, P; Kramer, L; D'Souza, J
    Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures
    NEUROLOGY
    
    R. Sachdeo et al., "Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures", NEUROLOGY, 57(5), 2001, pp. 864-871
86. Sato, Y; Kondo, I; Ishida, S; Motooka, H; Takayama, K; Tomita, Y; Maeda, H; Satoh, K
    Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy
    NEUROLOGY
    
    Y. Sato et al., "Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy", NEUROLOGY, 57(3), 2001, pp. 445-449
87. Meador, KJ; Loring, DW; Ray, PG; Murro, AM; King, DW; Perrine, KR; Vazquez, BR; Kiolbasa, T
    Differential cognitive and behavioral effects of carbamazepine and lamotrigine
    NEUROLOGY
    
    K.J. Meador et al., "Differential cognitive and behavioral effects of carbamazepine and lamotrigine", NEUROLOGY, 56(9), 2001, pp. 1177-1182
88. Fisher, RS; Sachdeo, RC; Pellock, J; Penovich, PE; Magnus, L; Bernstein, P
    Rapid initiation of gabapentin - A randomized, controlled trial
    NEUROLOGY
    
    R.S. Fisher et al., "Rapid initiation of gabapentin - A randomized, controlled trial", NEUROLOGY, 56(6), 2001, pp. 743-748
89. Hsia, SH
    Modern pharmacotherapies for type 2 diabetes mellitus
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
    
    S.H. Hsia, "Modern pharmacotherapies for type 2 diabetes mellitus", J NAT MED A, 93(9), 2001, pp. 335-349
90. Fellner, MJ; Sapadin, AN
    Current therapy of pemphigus vulgaris
    MOUNT SINAI JOURNAL OF MEDICINE
    
    M.J. Fellner e A.N. Sapadin, "Current therapy of pemphigus vulgaris", MT SINAI J, 68(4-5), 2001, pp. 268-278
91. Figuera, R; Rivero, N; Pajuelo, F; Font, P; Leyra, F; de la Camara, R; Arranz, R; Ranada, JMF
    Initial empiric therapy of febrile neutropenia with antibiotic monotherapy. Piperacillin/tazobactam versus imipenem/cilastatin (1994-1996)
    MEDICINA CLINICA
    
    R. Figuera et al., "Initial empiric therapy of febrile neutropenia with antibiotic monotherapy. Piperacillin/tazobactam versus imipenem/cilastatin (1994-1996)", MED CLIN, 116(16), 2001, pp. 610-611
92. Bondy, SJ; Iscoe, NA; Rothwell, DM; Gort, EH; Fleshner, NE; Paszat, LF; Browman, GP
    Trends in hormonal management of prostate cancer: A population-based studyin Ontario
    MEDICAL CARE
    
    S.J. Bondy et al., "Trends in hormonal management of prostate cancer: A population-based studyin Ontario", MED CARE, 39(4), 2001, pp. 384-396
93. Marson, AG; Chadwick, DW
    New drug treatments for epilepsy
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    
    A.G. Marson e D.W. Chadwick, "New drug treatments for epilepsy", J NE NE PSY, 70(2), 2001, pp. 143-147
94. Martin, R; Meador, K; Turrentine, L; Faught, E; Sinclair, K; Kuzniecky, R; Gilliam, F
    Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults
    EPILEPSIA
    
    R. Martin et al., "Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults", EPILEPSIA, 42(6), 2001, pp. 764-771
95. Kwan, P; Brodie, MJ
    Effectiveness of first antiepileptic drug
    EPILEPSIA
    
    P. Kwan e M.J. Brodie, "Effectiveness of first antiepileptic drug", EPILEPSIA, 42(10), 2001, pp. 1255-1260
96. Perucca, E
    The management of refractory idiopathic epilepsies
    EPILEPSIA
    
    E. Perucca, "The management of refractory idiopathic epilepsies", EPILEPSIA, 42, 2001, pp. 31-35
97. Gumel, AB; Loewen, TD; Shivakumar, PN; Sahai, BM; Yu, P; Garba, ML
    Numerical modelling of the perturbation of HIV-1 during combination anti-retroviral therapy
    COMPUTERS IN BIOLOGY AND MEDICINE
    
    A.B. Gumel et al., "Numerical modelling of the perturbation of HIV-1 during combination anti-retroviral therapy", COMPUT BIOL, 31(5), 2001, pp. 287-301
98. Borbolla, JR; Lopez-Hernandez, MA; Gonzalez-Avante, M; DeDiego, J; Trueba, E; Alvarado, ML; Jimenez, RM
    Comparison of cefepime versus ceftriaxone-amikacin as empirical regimens for the treatment of febrile neutropenia in acute leukemia patients
    CHEMOTHERAPY
    
    J.R. Borbolla et al., "Comparison of cefepime versus ceftriaxone-amikacin as empirical regimens for the treatment of febrile neutropenia in acute leukemia patients", CHEMOTHERA, 47(5), 2001, pp. 381-384
99. Jandula, BM; Martino, R; Gurgi, M; Manteiga, R; Sierra, J
    Treatment of febrile neutropenia with cefepime monotherapy
    CHEMOTHERAPY
    
    B.M. Jandula et al., "Treatment of febrile neutropenia with cefepime monotherapy", CHEMOTHERA, 47(3), 2001, pp. 226-231
100. Kupka, RW; Nolen, WA; Altshuler, LL; Denicoff, KD; Frye, MA; Leverich, GS; Keck, PE; McElroy, SL; Rush, AJ; Suppes, T; Post, RM
     The Stanley Foundation Bipolar Network 2. Preliminary summary of demographics, course of illness and response to novel treatments
     BRITISH JOURNAL OF PSYCHIATRY
     
     R.W. Kupka et al., "The Stanley Foundation Bipolar Network 2. Preliminary summary of demographics, course of illness and response to novel treatments", BR J PSYCHI, 178, 2001, pp. S177-S183